Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Budesonide for BPD Prevention in Preterm Infants (NEuroSIS)
NCT01035190Phase 3Completed
- Sponsor
- University Children's Hospital Tübingen
- Start
- Apr 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of budesonide in bronchopulmonary dysplasia (BPD), sponsored by University Children's Hospital Tübingen. Started Apr 2010; status: completed.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT01035190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01035190.